Brief: Inari Medical Announces First Patient Enrolled In Randomized Controlled Trial Of Flowtriever® System In Pulmonary Embolism

Inari Medical

15/02/2022 13:13

Feb 15 (Reuters) - Inari Medical Inc  NARI.O :
    * INARI MEDICAL ANNOUNCES FIRST PATIENT ENROLLED IN THE
PEERLESS
TRIAL, A RANDOMIZED CONTROLLED TRIAL EVALUATING OUTCOMES OF THE
FLOWTRIEVER® SYSTEM IN PULMONARY EMBOLISM PATIENTS

Source text for Eikon:  ID:nGNXcbwzN8 
Further company coverage:  NARI.O 

 ((Reuters.Briefs@thomsonreuters.com;))